These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1503417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC, Shiau YC, Chang WC, Kao CH, Lin CC.
    Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
    [Abstract] [Full Text] [Related]

  • 3. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer.
    Sliutz G, Tempfer C, Kainz C, Mustafa G, Gitsch G, Koelbl H, Biegelmayer C.
    Anticancer Res; 1995; 15(3):1127-9. PubMed ID: 7645936
    [Abstract] [Full Text] [Related]

  • 4. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P.
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [Abstract] [Full Text] [Related]

  • 5. Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia.
    Tramonti G, Ferdeghini M, Donadio C, Norpoth M, Annichiarico C, Bianchi R, Bianchi C.
    Cancer Detect Prev; 2000; 24(1):86-90. PubMed ID: 10757127
    [Abstract] [Full Text] [Related]

  • 6. [Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer].
    Joura E, Gitsch G, Kainz C, Fröhlich B, Biegelmayr C, Kölbl H.
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():115. PubMed ID: 1286308
    [No Abstract] [Full Text] [Related]

  • 7. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C, Sliutz G, Mustafa G, Bieglmayr C, Koelbl H, Reinthaller A, Gitsch G.
    Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
    [Abstract] [Full Text] [Related]

  • 8. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
    Ngan HY, Cheng GT, Yeung WS, Wong LC, Ma HK.
    Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
    [Abstract] [Full Text] [Related]

  • 9. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG.
    J Clin Oncol; 2005 Mar 01; 23(7):1455-62. PubMed ID: 15735121
    [Abstract] [Full Text] [Related]

  • 10. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
    Forni F, Ferrandina G, Deodato F, Macchia G, Morganti AG, Smaniotto D, Luzi S, D'Agostino G, Valentini V, Cellini N, Giardina B, Scambia G.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1145-9. PubMed ID: 17689030
    [Abstract] [Full Text] [Related]

  • 11. Cancer of the uterine cervix: clinical value of squamous cell carcinoma antigen (SCC) measurements.
    Lozza L, Merola M, Fontanelli R, Stefanon B, Seregni E, Bombardieri E, De Palo G.
    Anticancer Res; 1997 Nov 15; 17(1B):525-9. PubMed ID: 9066575
    [Abstract] [Full Text] [Related]

  • 12. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A, Tana R, Cosio S, Genazzani AR.
    Crit Rev Oncol Hematol; 2008 Apr 15; 66(1):10-20. PubMed ID: 17964182
    [Abstract] [Full Text] [Related]

  • 13. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB.
    Gynecol Oncol; 2000 Apr 15; 77(1):164-70. PubMed ID: 10739706
    [Abstract] [Full Text] [Related]

  • 14. [The value of marker antigens TPS, SCC and CEA in diagnosis, evaluation of histologic type and clinical disease progression in patients with cervical carcinoma].
    Zakrzewska I.
    Pol Merkur Lekarski; 2001 Jan 15; 10(55):21-3. PubMed ID: 11320545
    [Abstract] [Full Text] [Related]

  • 15. Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
    Gadducci A, Tana R, Fanucchi A, Genazzani AR.
    Gynecol Oncol; 2007 Oct 15; 107(1 Suppl 1):S23-6. PubMed ID: 17727924
    [Abstract] [Full Text] [Related]

  • 16. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H, Schwörer D, Pfleiderer A.
    Geburtshilfe Frauenheilkd; 1989 Mar 15; 49(3):266-71. PubMed ID: 2721888
    [Abstract] [Full Text] [Related]

  • 17. Serum tissue polypeptide specific antigen (TPS) in patients with cervical carcinoma: preliminary report.
    Pattaranutaporn P, Chansilpa Y, Tangkarat S, Tepmongkol P, Sangruchi S, Senapad S.
    Anticancer Res; 1997 Mar 15; 17(3C):2309-12. PubMed ID: 9216707
    [Abstract] [Full Text] [Related]

  • 18. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 15; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 19. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
    Micke O, Prott FJ, Schäfer U, Tangerding S, Pötter R, Willich N.
    Anticancer Res; 2000 Jan 15; 20(6D):5113-5. PubMed ID: 11326679
    [Abstract] [Full Text] [Related]

  • 20. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma.
    Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D.
    Cancer; 1999 Mar 01; 85(5):1018-25. PubMed ID: 10091783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.